262 related articles for article (PubMed ID: 15949941)
1. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
2. Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex.
Rodríguez A; Freixes M; Dalfó E; Martín M; Puig B; Ferrer I
Neuroscience; 2005; 131(4):825-32. PubMed ID: 15749337
[TBL] [Abstract][Full Text] [Related]
3. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions.
Dalfó E; Albasanz JL; Martin M; Ferrer I
Brain Pathol; 2004 Oct; 14(4):388-98. PubMed ID: 15605986
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor/phospholipase C system in female rat heart.
Iglesias I; Castillo CA; León D; Ruíz MA; Albasanz JL; Martín M
Brain Res; 2007 Jun; 1153():1-11. PubMed ID: 17493590
[TBL] [Abstract][Full Text] [Related]
5. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
Shiozaki K; Iseki E
J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
[TBL] [Abstract][Full Text] [Related]
6. Abnormal group I metabotropic glutamate receptor expression and signaling in the frontal cortex in Pick disease.
Dalfó E; Albasanz JL; Rodríguez A; Martín M; Ferrer I
J Neuropathol Exp Neurol; 2005 Jul; 64(7):638-47. PubMed ID: 16042316
[TBL] [Abstract][Full Text] [Related]
7. Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
Neurosci Lett; 2006 Dec; 410(2):115-20. PubMed ID: 17084974
[TBL] [Abstract][Full Text] [Related]
8. Metabotropic glutamate receptor/phospholipase C pathway is increased in rat brain at the end of pregnancy.
León D; Castillo CA; Ruiz MA; Albasanz JL; Martín M
Neurochem Int; 2007 Apr; 50(5):681-8. PubMed ID: 17303286
[TBL] [Abstract][Full Text] [Related]
9. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
10. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
Ferrer I; Perez E; Dalfó E; Barrachina M
Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
[TBL] [Abstract][Full Text] [Related]
11. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
Lee HG; Ogawa O; Zhu X; O'Neill MJ; Petersen RB; Castellani RJ; Ghanbari H; Perry G; Smith MA
Acta Neuropathol; 2004 Apr; 107(4):365-71. PubMed ID: 14872255
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
Shepherd CE; McCann H; Thiel E; Halliday GM
Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
[TBL] [Abstract][Full Text] [Related]
14. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
[TBL] [Abstract][Full Text] [Related]
15. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
Sauer J; ffytche DH; Ballard C; Brown RG; Howard R
Brain; 2006 Jul; 129(Pt 7):1780-8. PubMed ID: 16670180
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
17. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
18. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex.
Hannan AJ; Blakemore C; Katsnelson A; Vitalis T; Huber KM; Bear M; Roder J; Kim D; Shin HS; Kind PC
Nat Neurosci; 2001 Mar; 4(3):282-8. PubMed ID: 11224545
[TBL] [Abstract][Full Text] [Related]
19. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
[TBL] [Abstract][Full Text] [Related]
20. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex.
Lian Q; Ladner CJ; Magnuson D; Lee JM
Exp Neurol; 2001 Jan; 167(1):158-65. PubMed ID: 11161603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
